*By Michael Teich* Ethical issues could be the Achilles heel for Juul, the $15 billion company behind the vaping devices infiltrating college and high school campuses. "The valuation is justified on the math," said Dan Primack, Business Editor at Axios. The real question, though, is, "Does it want to stop kids from getting these?" The sleek and colorful design of the company's e-cigarettes, paired with appealing flavors such as mango and cool mint, has helped Juul emerge as a leader in the market with a 68 percent share, according to Wells Fargo. The company projects $940 million in revenue this year, but Primack said he's told that "they are blowing through those numbers." Those numbers helped Juul raise a fresh $1.2 billion in new funding last week. But strong sales growth may not be enough to entice more traditional Silicon Valley investors to overlook the moral complexities of Juul's business, Primack said. While the device was created as an alternative to cigarettes, he pointed out the product is falling into the hands of first-time smokers and serves as a "gateway smoke." For the full segment, [click here.](https://cheddar.com/videos/the-ethical-issues-that-may-plague-juuls-future)

Share:
More In Business
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More